Skip to content
Home/Companies/Biotech/Insempra
IN

Insempra

Biotech·Germany·Active·2yr hold

Insempra is a biotech company, headquartered in Germany.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Insempra?

Insempra is currently owned by Possible Ventures through Possible Ventures Fund III (2023 vintage), since 2024. Across its history, Insempra has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Possible Ventures
Most recent investor
Possible Ventures
Possible Ventures Fund III · 2023 · VC
3 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by BlueYard Capital, Henkel Ventures and Possible Ventures since 2020.
Co-invest · 3 holders · 2020 · present
BlueYard Capital
BlueYard CapitalActive
2020 · present · BlueYard Capital Fund II · 2019 · VC
MOIC
–
Possible Ventures
Possible VenturesActive
2024 · present · Possible Ventures Fund III · 2023 · VC
MOIC
–
Henkel Ventures
Henkel VenturesActive
2024 · present · Henkel Ventures Balance-Sheet Vehicle · 2017 · Evergreen
MOIC
–

More from Possible Ventures Fund III

Other portfolio companies in the same fund.

Coherence Neuro
Active
BiotechUnited Kingdom· 2025
Telura Energy
Active
EnergyGermany· 2025
Cosmic Aerospace
Active
MobilityUnited States· 2024
HyperHeat
Active
EnergyGermany· 2024
Automata
Active
IndustrialsUnited Kingdom· 2023
Chemify
Active
Deep TechUnited Kingdom· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings